U.S. markets closed

Eledon Pharmaceuticals, Inc. (ELDN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.000.00 (0.00%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 9/18/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 2.00
52-Week Change 3-56.40%
S&P500 52-Week Change 335.11%
52 Week High 327.32
52 Week Low 35.91
50-Day Moving Average 37.07
200-Day Moving Average 39.05

Share Statistics

Avg Vol (3 month) 369.05k
Avg Vol (10 day) 398.63k
Shares Outstanding 514.31M
Implied Shares Outstanding 6N/A
Float 8.71M
% Held by Insiders 19.27%
% Held by Institutions 165.96%
Shares Short (Aug 30, 2021) 4132.59k
Short Ratio (Aug 30, 2021) 41.69
Short % of Float (Aug 30, 2021) 40.93%
Short % of Shares Outstanding (Aug 30, 2021) 40.93%
Shares Short (prior month Jul 29, 2021) 4165.32k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 04, 2020
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-15.90%
Return on Equity (ttm)-29.73%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -24.78M
Net Income Avi to Common (ttm)-27.93M
Diluted EPS (ttm)-3.33
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)101.13M
Total Cash Per Share (mrq)7.07
Total Debt (mrq)269k
Total Debt/Equity (mrq)0.15
Current Ratio (mrq)38.32
Book Value Per Share (mrq)12.48

Cash Flow Statement

Operating Cash Flow (ttm)-22.61M
Levered Free Cash Flow (ttm)-7.82M